Your browser doesn't support javascript.
loading
Is the Use of Proton-pump Inhibitors a Risk Factor for Alzheimer's Disease? Molecular Mechanisms and Clinical Implications.
Ide, Kazuki; Matsuoka, Norihiro; Kawakami, Koji.
Affiliation
  • Ide K; Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan.
  • Matsuoka N; Center for the Promotion of Interdisciplinary Education and Research, Kyoto University, Yoshida-honmachi, Sakyo-ku, Kyoto 606-8501, Japan.
  • Kawakami K; Jyoto Hospital, 11-22 Hanatenhigashi 2-chome, Tsurumi-ku Osaka-shi, Osaka, 538-0044, Japan.
Curr Med Chem ; 25(18): 2166-2174, 2018.
Article in En | MEDLINE | ID: mdl-29376492
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: 2-Pyridinylmethylsulfinylbenzimidazoles / Proton Pump Inhibitors / Alzheimer Disease Type of study: Etiology_studies / Risk_factors_studies Limits: Aged / Aged80 / Humans / Middle aged Language: En Journal: Curr Med Chem Journal subject: QUIMICA Year: 2018 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: 2-Pyridinylmethylsulfinylbenzimidazoles / Proton Pump Inhibitors / Alzheimer Disease Type of study: Etiology_studies / Risk_factors_studies Limits: Aged / Aged80 / Humans / Middle aged Language: En Journal: Curr Med Chem Journal subject: QUIMICA Year: 2018 Document type: Article Affiliation country: Country of publication: